Volume 22 Issue 8
Aug.  2024
Turn off MathJax
Article Contents
MA Chengcheng, ZHANG Weiying, LIU Shijun, LI Bo, YE Xuhui. Analysis of the effectiveness of digitized management in integrated medical and preventive care for hypertension through chronic diseases outpatient services[J]. Chinese Journal of General Practice, 2024, 22(8): 1376-1380. doi: 10.16766/j.cnki.issn.1674-4152.003640
Citation: MA Chengcheng, ZHANG Weiying, LIU Shijun, LI Bo, YE Xuhui. Analysis of the effectiveness of digitized management in integrated medical and preventive care for hypertension through chronic diseases outpatient services[J]. Chinese Journal of General Practice, 2024, 22(8): 1376-1380. doi: 10.16766/j.cnki.issn.1674-4152.003640

Analysis of the effectiveness of digitized management in integrated medical and preventive care for hypertension through chronic diseases outpatient services

doi: 10.16766/j.cnki.issn.1674-4152.003640
Funds:

 2022KY1056

 202139

 ZD20210031

  • Received Date: 2023-12-03
    Available Online: 2024-11-19
  •   Objective   To enhance hypertension management in primary medical institutions by analyzing the effectiveness of digitized management of medical-preventive integration for hypertension based on integrated outpatient services for chronic diseases.   Methods   In September 2021, 772 hypertensive patients aged 35-79 were selected from the outpatient department of Kaixuan Subdistrict Community Healthcare Center. According to the random principle, 388 cases were assigned to the intervention group and 384 to the control group. The intervention group adopted digitized management of medical-preventive integration based on integrated outpatient services for chronic diseases, while the control group adopted a routine community hypertension management based on general outpatient services. After 18 months of intervention, statistical analysis assessed changes in lifestyle, blood pressure compliance rate, and combined compliance rats for blood pressure, blood glucose, and lipid levels in both groups before and after intervention. Factors influencing blood pressure compliance at the study endpoint were also analyzed.   Results   Following the intervention, the alcohol consumption, obesity, and abdominal obesity rates in the intervention group were improved [18.8% (73 cases) vs. 27.1% (104 cases), 5.4% (21 cases) vs. 11.7% (45 cases), 31.2% (121 cases) vs. 45.1% (173 cases), respectively], which were statistically significant compared to the control group (χ2=7.468, 19.627, 15.738, P < 0.05). The blood pressure compliance rate and the combined compliance rate of blood pressure, blood glucose, and lipid in the intervention group [61.9% (240 cases) and 53.4% (207 cases), respectively] were higher than those in the control group [44.3% (170 cases) and 28.1% (108 cases), respectively], with statistically significant (χ2=23.964, 50.843, P < 0.05). Multivariate logistic regression analysis showed that receiving digital integrated medical and preventive management (OR=1.587, 95% CI: 1.161-2.171), blood glucose control (OR=2.056, 95% CI: 1.294-3.266), and blood lipid control (OR=1.490, 95% CI: 1.042-2.131) were independent promoting factors for blood pressure control (P < 0.05).   Conclusion   The digitized management of medical-preventive integration based on integrated chronic disease outpatient services can improve the effectiveness of blood pressure disease management.

     

  • loading
  • [1]
    国家心血管病中心, 国家基本公共卫生服务项目基层高血压管理办公室, 国家基层高血压管理专家委员会. 国家基层高血压防治管理指南2020版[J]. 中国循环杂志, 2021, 36(3): 209-220.

    National Center for Cardiovascular Diseases, The National Essential Public Health Service Program Office for Management of Hypertension in Primary Health Care, National Committee on Hypertension Management in Primary Health Care. National clinical practice guidelines on the management of hypertension in primary health care in China (2020)[J]. Chinese Circulation Journal, 2021, 36(3): 209-220.
    [2]
    石剑锋, 洪卫民, 上官雪鸿, 等. 三明市梅列区徐碧街道高血压医防协同融合成效分析[J]. 医学理论与实践, 2021, 34(22): 4008-4010.

    SHI J F, HONG W M, SHANGGUAN X H, et al. Analysis of the effectiveness of medical -preventive collaboration for hypertension in Xubi Subdistrict, Meilie District, Sanming City[J]. The Journal of Medical Theory and Practice, 2021, 34(22): 4008-4010
    [3]
    陈洁, 林维, 夏生林, 等. 互联网+医防融合模式对社区老年高血压患者的疗效研究[J]. 中国实用医药, 2022, 17(18): 173-177.

    CHEN J, LIN W, XIA S L, et al. Study on the efficacy of internet combined with medical-prevention integration model on elderly hypertension patients in the community[J]. China Practical Medicine, 2022, 17(18): 173-177.
    [4]
    解夕黎, 孙明, 贾雯涵, 等. "大数据时代"下慢性病防控新模式的研究进展[J]. 中国全科医学, 2022, 25(22): 2811-2814. doi: 10.12114/j.issn.1007-9572.2022.0165

    XIE X L, SUN M, JIA W H, et al. Recent advances in models using big data techniques for the prevention and control of noncommunicable diseases[J]. Chinese General Practice, 2022, 25(22): 2811-2814. doi: 10.12114/j.issn.1007-9572.2022.0165
    [5]
    屈展, 刘凯. 人工智能技术在高血压诊疗中的应用进展[J]. 心血管病学进展, 2023, 44(1): 48-50, 56.

    QU Z, LIU K. Applications of artificial intelligence for hypertension management[J]. Advances in Cardiovascular Diseases, 2023, 44(1): 48-50, 56.
    [6]
    郭轩荧, 杨帆. 我国基层慢性病医防融合的多种实践形式与推进障碍[J]. 南京医科大学学报(社会科学版), 2021, 21(3): 201-206.

    GUO X Y, YANG F. Integration modes of treatment and prevention about chronic diseaseand its implement obstacle in China[J]. Journal of Nanjing Medical University(Social Sciences), 2021, 21(3): 201-206.
    [7]
    吕奕鹏, 程帆, 张晓琼, 等. 新时期我国基层公共卫生服务发展现况与展望[J]. 中华全科医学, 2022, 20(10): 1631-1634. doi: 10.16766/j.cnki.issn.1674-4152.002666

    LYU Y P, CHENG F, ZHANG X Q, et al. The current situation and prospect of the primary public health services in China in the new era[J]. Chinese Journal of General Practice, 2022, 20(10): 1631-1634. doi: 10.16766/j.cnki.issn.1674-4152.002666
    [8]
    中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理指南(2022)[J]. 中华内科杂志, 2022, 61(3): 249-262. doi: 10.3760/cma.j.cn112138-20220120-000063

    Chinese Diabetes Society, National Office for Primary Diabetes Care. National guidelines for the prevention and control of diabetes in primary care (2022)[J]. Chinese Journal of Internal Medicine, 2022, 61(3): 249-262. doi: 10.3760/cma.j.cn112138-20220120-000063
    [9]
    中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中国循环杂志, 2023, 38(3): 237-271. doi: 10.3969/j.issn.1000-3614.2023.03.001

    Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023)[J]. Chinese Circulation Journal, 2023, 38(3): 237-271. doi: 10.3969/j.issn.1000-3614.2023.03.001
    [10]
    中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 等. 中国居民肥胖防治专家共识[J]. 中华流行病学杂志, 2022, 43(5): 609-626. doi: 10.3760/cma.j.cn112338-20220402-00253

    Chinese Nutrition Society Obesity Prevention and Control Section, Chinese Nutrition Society Clinical Nutrition Section, Chinese Preventive Medicine Association Behavioral Health Section, et al. Expert consensus on obesity prevention and treatment in China[J]. Chinese Journal of Epidemiology, 2022, 43(5): 609-626. doi: 10.3760/cma.j.cn112338-20220402-00253
    [11]
    程晓冉, 张笑天, 李明月, 等. 医防融合背景下慢性病随访对高血压和糖尿病患者健康行为及血压/血糖控制的影响研究[J]. 中国全科医学, 2023, 26(28): 3482-3488.

    CHENG X R, ZHANG X T, LI M Y, et al. Impact of chronic diseases follow-up on health behaviors and blood pressure/glucose control of patients with hypertension and diabetes in the context of treatment-prevention integration[J]. Chinese General Practice, 2023, 26(28): 3482-3488.
    [12]
    史威力, 王留义, 李明艳, 等. 基于慢病管理路径的社区高血压患者管理效果评价[J]. 中华全科医学, 2022, 20(11): 1893-1896. doi: 10.16766/j.cnki.issn.1674-4152.002729

    SHI W L, WANG L Y, LI M Y, et al. Effect evaluation of community hypertension patients ' management based on chronic disease management pathway[J]. Chinese Journal of General Practice, 2022, 20(11): 1893-1896. doi: 10.16766/j.cnki.issn.1674-4152.002729
    [13]
    马程乘, 朱虹玮, 章炜颖, 等. 数智赋能的基层"两慢病"医防融合管理优化路径构建与实践[J]. 中国农村卫生, 2024, 16(2): 18-23.

    MA C C, ZHU H W, ZHANG W Y, et al. Construction and practice of an optimized path for the integration of medical and preventive management of "two chronic diseases" empowered by digital intelligence in primary healthcare institution[J]. China Rural Health, 2024, 16(2): 18-23.
    [14]
    王继光. 高血压数字平台和数字疗法[J]. 临床心血管病杂志, 2022, 38(8): 606-609.

    WANG J G. Digital platforms and digital therapeutics for the management of hypertension[J]. Journal of Clinical Cardiology, 2022, 38(8): 606-609.
    [15]
    黄永艳, 杨丽娜, 曹久妹, 等. 基于云数据的门诊高血压监测[J]. 诊断学理论与实践, 2020, 19(3): 319-324.

    HUANG Y Y, YANG L N, CAO J M, et al. Cloud-based solution assisted blood pressure management in outpatient setting[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(3): 319-324.
    [16]
    刘书情, 周妍. 肥胖相关性高血压的神经内分泌机制研究进展[J]. 浙江医学, 2021, 43(16): 1805-1809.

    LIU S Q, ZHOU Y. Research progress on the neuroendocrine mechanism of obesity related hypertension[J]. Zhejiang Medical Journal, 2021, 43(16): 1805-1809.
    [17]
    吴洵, 覃玉, 苏健, 等. 心血管病高危人群腰围和体重变化与血压水平变化关系的随访研究[J]. 中华流行病学杂志, 2022, 43(12): 1900-1906.

    WU X, QIN Y, SU J, et al. Follow-up study on the relationship between changes in waist circumference and body weight and changes in blood pressure levels among high cardiovascular risk population[J]. Chinese Journal of Epidemiology, 2022, 43(12): 1900-1906.
    [18]
    关云琦, 梁明斌, 何青芳, 等. 浙江省成年居民饮酒与高血压的关联研究[J]. 预防医学, 2021, 33(9): 877-883.

    GUAN Y Q, LIANG M B, HE Q F, et al. Association between alcohol consumption and hypertension in adults of Zhejiang Province[J]. Preventive Medicine, 2021, 33(9): 877-883.
    [19]
    LI R, LIANG N, BU F, et al. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis[J]. JMIR Mhealth Uhealth, 2020, 8(3): e17776. . doi: 10.2196/17776
    [20]
    北京高血压防治协会, 北京糖尿病防治协会, 北京慢性病防治与健康教育研究会, 等. 基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版), 2020, 12(8): 1-73.

    Beijing Association for the Prevention and Control of Hypertension, Beijing Association for the Prevention and Control of diabetes, Beijing Association for Chronic Disease Prevention and Health Education, et al. Practise guideline (2020) for integrated management of cardiovascular diseases in primary hospitals[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2020, 12(8): 1-73.
    [21]
    中华预防医学会, 中华预防医学会心脏病预防与控制专业委员会, 中华医学会糖尿病学分会, 等. 中国健康生活方式预防心血管代谢疾病指南[J]. 中华预防医学杂志, 2020, 54(3): 256-277.

    Chinese Preventive Medicine Association, Chinese Preventive Medicine Association Heart Disease Prevention and Control Professional Committee, Chinese Medical Association diabetes Branch, et al. Chinese guideline on healthy lifestyle to prevent cardiometabolic diseases[J]. Chinese Journal of Preventive Medicine, 2020, 54(3): 256-277.
    [22]
    于宁, 张梅, 张笑, 等. 中国中老年居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J]. 中华流行病学杂志, 2023, 44(2): 196-204.

    YU N, ZHANG M, ZHANG X, et al. Study on the status and influencing factors of comorbidity of hypertension, diabetes, and dyslipidemia among middle-aged and elderly Chinese adults[J]. Chinese Journal of Epidemiology, 2023, 44(2): 196-204.
    [23]
    张明, 刘杰, 涂青云, 等. 危险因素聚集性与主要心脑血管事件发生风险的前瞻性队列研究[J]. 江苏预防医学, 2021, 32(6): 649-653.

    ZHANG M, LIU J, TU Q Y, et al. A prospective cohort study on the clustering of risk factors and the risk of major adverse cardiovascular events[J]. Jiangsu Journal of Preventive Medicine, 2021, 32(6): 649-653.
    [24]
    "三高"共管规范化诊疗中国专家共识(2023版)专家组. "三高"共管规范化诊疗中国专家共识(2023版)[J/OL]. 中华心血管病杂志(网络版), 2023, 6: e1000144. DOI: 10.3760/cma.j.cn116031.2023.1000144.

    Expert Group on Standardized Diagnosis and Treatment of "Three Highs" in China (2023 Edition). Chinese expert consensus on standardized diagnosis and treatment of "Three Highs" joint management (2023 edition)[J]. Chinese Video Journal of Cardiology, 2023, 6(1): 1-11.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(5)

    Article Metrics

    Article views (1) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return